SHARE THIS VIDEO —
CEO to lower drug price after controversy
CNBC’s Meg Tirrell and LSU Health Sciences Center’s Dr. Corey Hebert discuss Turing Pharmaceutical CEO Martin Shkreli’s decision to lower the price of prescription drug Daramprim after raising the price from $13.50 to $750 yesterday.